Literature DB >> 24462005

Histopathologic and immunohistochemical sequelae of bariatric embolization in a porcine model.

Ben E Paxton1, Christopher L Alley2, Jennifer H Crow2, James Burchette2, Clifford R Weiss3, Dara L Kraitchman3, Aravind Arepally4, Charles Y Kim5.   

Abstract

PURPOSE: To evaluate the histopathologic sequelae of bariatric embolization on the gastric mucosa and to correlate with immunohistochemical evaluation of the gastric fundus, antrum, and duodenum.
MATERIALS AND METHODS: This study was performed on 12 swine stomach and duodenum specimens after necropsy. Of the 12 swine, 6 had previously undergone bariatric embolization of the gastric fundus, and the 6 control swine had undergone a sham procedure with saline. Gross pathologic, histopathologic, and immunohistochemical examinations of the stomach and duodenum were performed. Specifically, mucosal integrity, fibrosis, ghrelin-expressing cells, and gastrin-expressing cells were assessed.
RESULTS: Gross and histopathologic evaluation of treatment animals showed healing or healed mucosal ulcers in 50% of animals, with gastritis in 100% of treatment animals and in five of six control animals. The ghrelin-immunoreactive mean cell density was significantly lower in the gastric fundus in the treated animals compared with control animals (15.3 vs 22.0, P < .01) but similar in the gastric antrum (9.3 vs 14.3, P = .08) and duodenum (8.5 vs 8.6, P = .89). The gastrin-expressing cell density was significantly lower in the antrum of treated animals compared with control animals (82.2 vs 126.4, P = .03). A trend toward increased fibrosis was suggested in the gastric fundus of treated animals compared with controls (P = .07).
CONCLUSIONS: Bariatric embolization resulted in a significant reduction in ghrelin-expressing cells in the gastric fundus without evidence of upregulation of ghrelin-expressing cells in the duodenum. Healing ulcerations in half of treated animals underscores the need for additional refinement of this procedure.
© 2014 Published by SIR on behalf of The Society of Interventional Radiology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24462005      PMCID: PMC4040229          DOI: 10.1016/j.jvir.2013.09.016

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  29 in total

1.  Ghrelin suppression and fat loss after left gastric artery embolization in canine model.

Authors:  Dilmurat Bawudun; Yan Xing; Wen-Ya Liu; Yu-Jie Huang; Wei-Xin Ren; Mei Ma; Xiao-Dong Xu; Gao-Jun Teng
Journal:  Cardiovasc Intervent Radiol       Date:  2012-02-25       Impact factor: 2.740

2.  Bariatric embolization for suppression of the hunger hormone ghrelin in a porcine model.

Authors:  Ben E Paxton; Charles Y Kim; Christopher L Alley; Jennifer H Crow; Bryan Balmadrid; Christopher G Keith; Ravi J Kankotia; Sandra Stinnett; Aravind Arepally
Journal:  Radiology       Date:  2012-11-30       Impact factor: 11.105

3.  Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors.

Authors:  T M Loftus; D E Jaworsky; G L Frehywot; C A Townsend; G V Ronnett; M D Lane; F P Kuhajda
Journal:  Science       Date:  2000-06-30       Impact factor: 47.728

4.  A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans.

Authors:  D E Cummings; J Q Purnell; R S Frayo; K Schmidova; B E Wisse; D S Weigle
Journal:  Diabetes       Date:  2001-08       Impact factor: 9.461

5.  A role for ghrelin in the central regulation of feeding.

Authors:  M Nakazato; N Murakami; Y Date; M Kojima; H Matsuo; K Kangawa; S Matsukura
Journal:  Nature       Date:  2001-01-11       Impact factor: 49.962

6.  Ghrelin in domestic animals: distribution in stomach and its possible role.

Authors:  T Hayashida; K Murakami; K Mogi; M Nishihara; M Nakazato; M S Mondal; Y Horii; M Kojima; K Kangawa; N Murakami
Journal:  Domest Anim Endocrinol       Date:  2001-07       Impact factor: 2.290

7.  Density of ghrelin-producing cells is higher in the gastric mucosa of morbidly obese patients.

Authors:  Fabiana A N Maksud; Jairo S Alves; Marco T C Diniz; Alfredo J A Barbosa
Journal:  Eur J Endocrinol       Date:  2011-05-09       Impact factor: 6.664

Review 8.  Changes in ghrelin levels following bariatric surgery: review of the literature.

Authors:  Kevin Tymitz; Amy Engel; Sarah McDonough; Mary Pat Hendy; George Kerlakian
Journal:  Obes Surg       Date:  2011-01       Impact factor: 4.129

9.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

Review 10.  Gastric secretion.

Authors:  Shijian Chu; Mitchell L Schubert
Journal:  Curr Opin Gastroenterol       Date:  2012-11       Impact factor: 3.287

View more
  11 in total

1.  Bariatric Embolization of Arteries for the Treatment of Obesity (BEAT Obesity) Trial: Results at 1 Year.

Authors:  Clifford R Weiss; Godwin O Abiola; Aaron M Fischman; Lawrence J Cheskin; Jay Vairavamurthy; Brian P Holly; Olaguoke Akinwande; Franklin Nwoke; Kalyan Paudel; Stephen Belmustakov; Kelvin Hong; Rahul S Patel; Eun J Shin; Kimberley E Steele; Timothy H Moran; Richard E Thompson; Taylor Dunklin; Harvey Ziessman; Dara L Kraitchman; Aravind Arepally
Journal:  Radiology       Date:  2019-04-02       Impact factor: 11.105

2.  Clinical Safety of Bariatric Arterial Embolization: Preliminary Results of the BEAT Obesity Trial.

Authors:  Clifford R Weiss; Olaguoke Akinwande; Kaylan Paudel; Lawrence J Cheskin; Brian Holly; Kelvin Hong; Aaron M Fischman; Rahul S Patel; Eun J Shin; Kimberley E Steele; Timothy H Moran; Kristen Kaiser; Amie Park; David M Shade; Dara L Kraitchman; Aravind Arepally
Journal:  Radiology       Date:  2017-02-14       Impact factor: 11.105

Review 3.  Current and cutting-edge interventions for the treatment of obese patients.

Authors:  Jenanan Vairavamurthy; Lawrence J Cheskin; Dara L Kraitchman; Aravind Arepally; Clifford R Weiss
Journal:  Eur J Radiol       Date:  2017-05-19       Impact factor: 3.528

Review 4.  Bariatric Arterial Embolization for Obesity: A Review of Early Clinical Evidence.

Authors:  Bin-Yan Zhong; Godwin Abiola; Clifford R Weiss
Journal:  Cardiovasc Intervent Radiol       Date:  2018-06-05       Impact factor: 2.740

5.  Bariatric Embolization of the Left Gastric Arteries for the Treatment of Obesity: 9-Month Data in 5 Patients.

Authors:  Zhi-Bin Bai; Yong-Lin Qin; Gang Deng; Guo-Feng Zhao; Bin-Yan Zhong; Gao-Jun Teng
Journal:  Obes Surg       Date:  2018-04       Impact factor: 4.129

Review 6.  Bariatric embolization of the gastric arteries for the treatment of obesity.

Authors:  Clifford R Weiss; Andrew J Gunn; Charles Y Kim; Ben E Paxton; Dara L Kraitchman; Aravind Arepally
Journal:  J Vasc Interv Radiol       Date:  2015-03-14       Impact factor: 3.464

7.  Analysis of weight changes after left gastric artery embolization in a cancer-naive population.

Authors:  David J Kim; Hari S Raman; Amber Salter; Raja Ramaswamy; Andrew J Gunn; Clifford R Weiss; Olaguoke Akinwande
Journal:  Diagn Interv Radiol       Date:  2018 Mar-Apr       Impact factor: 2.630

8.  Effect of left or right gastric artery interventional embolization on obesity and ghrelin/leptin expression in pigs.

Authors:  Hui Liu; Xiangying Li; Rihui Chen; Dingcheng Liu; Chao Tong
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

Review 9.  Rationale and Preclinical Data Supporting Bariatric Arterial Embolization.

Authors:  Yingli Fu; Dara L Kraitchman
Journal:  Tech Vasc Interv Radiol       Date:  2020-01-11

10.  Bariatric Arterial Embolization with Calibrated Radiopaque Microspheres and an Antireflux Catheter Suppresses Weight Gain and Appetite-Stimulating Hormones in Swine.

Authors:  Clifford R Weiss; Yingli Fu; Cyrus Beh; Charles Hu; Dorota Kedziorek; Eun-Ji Shin; Robert A Anders; Aravind Arepally; Dara L Kraitchman
Journal:  J Vasc Interv Radiol       Date:  2020-08-14       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.